GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (XPAR:VIRP) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Virbac (XPAR:VIRP) Future 3-5Y EPS without NRI Growth Rate : 8.53 (As of Apr. 16, 2025)


View and export this data going back to 1989. Start your Free Trial

What is Virbac Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Virbac's Future 3-5Y EPS without NRI Growth Rate is 8.53.

Competitive Comparison of Virbac's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - General subindustry, Virbac's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Virbac's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Virbac's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Virbac's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Virbac  (XPAR:VIRP) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Virbac Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Virbac's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Virbac Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (XPAR:VIRP) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
XPAR:VETO XPAR:BOI XPAR:EAPI XPAR:AB XPAR:ALRPD XPAR:MLCOT XPAR:IPN LLY JNJ ABBV OCSE:NOVO B XSWX:ROG LSE:AZN MRK XSWX:NOVN AMGN PFE GILD XPAR:SAN BMY
Traded in Other Exchanges
VRBCF:USA VIRPp:UK 0NM7:UK V16:Germany V16:Germany
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Website
https://www.virbac.com
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by Asia and Latin America.

Virbac Headlines

No Headlines